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Although the identiﬁcation of the multigene family encoding mammalian olfactory receptors were
identiﬁed more than 20 years ago, we are far from understanding olfactory perception because of the
difﬁculties in functional expression of these receptors in heterologous cell systems. Cell-free (CF) or
in vitro expression systems offer an elegant alternative route to cell based protein expression, as the
functional expression of membrane proteins can be directly achieved from the genetic template without
the need of cell cultivation and protein isolation.
Here we investigated in detail the cell-free expression and membrane insertion of the olfactory re-
ceptor OR5 in dependence of different experimental conditions like probing different origins of the cell-
free expression system (from bacteria, via plants and insects toward mammalian system) and lipid
composition of the respective extracts. We provided substantial biochemical indications by radioactive
labeling based on [35S]-methionine, followed by proteolytic digestion, and we found that the insertion of
the olfactory receptor OR5 into liposomes resulted in an unidirectional orientation with the binding side
exposed into the aqueous space, resembling the native orientation in the cilia of the olfactory neurons.
We report the different results in synthesis capacity for the different in vitro systems employed as we like
to demonstrate the ﬁrst in vitro kit toward and ex situ and ex vivo odorant receptor array.
 2013 The Authors. Published by Elsevier Masson SAS. Open access under CC BY-NC-SA license.1. Introduction
The fascinating sense of smell enables most organisms to detect
food, predators, mates and danger. The majority (40e50%) of the
pharmaceutically relevant family of seven transmembrane G-pro-
tein-coupled receptors (GPCRs) in humans is covered by approxi-
mately 390 odorant receptors, which reﬂects their important role
in evolution and their ability to perceive a large number of odorants
[1,2]. Each olfactory receptor recognizes multiple odorants and
each odorant is detected by a speciﬁc combination of olfactory re-
ceptors. Because of this complexity and the lack of appropriate
screening systems, most of the odorant receptors are still orphan.
Single odorant receptors have been expressed in heterologous cells.
.
r Masson SAS. Open access under CC but overexpression of membrane proteins, especially odorant re-
ceptors, in heterologous systems is hampered by cell toxicity, for-
mation of inclusion bodies or the lack of plasma membrane
transport [3,4]. This difﬁcult situation has been improved by the
production of odorant receptor chimeras with e.g. the adrenergic
[3]or rhodopsin receptor [5], as well as by odorant receptor frag-
ments, lacking the N-terminus and the ﬁrst transmembrane region
[6]. Those strategies are applicable in respect to the synthesis ef-
ﬁciency; however, if functional studies about the respective protein
species are envisioned, it is difﬁcult to interpret such invasive
modiﬁcations in the respective protein structure.
Cell-free (CF) protein synthesis alternatively referred to in vitro
expression systems offer an elegant route for the expression of
membrane proteins, deriving from the unaltered cDNA sequence,
known from the genome databases. Here, the genetic template, the
complementary DNA (cDNA) is transcribed and subsequently
translated into the respective protein and e in case of membrane
proteinsewe observed the spontaneous insertion into membrane-
like amphiphilic surroundings. In vitro expression systems have
been ﬁrst described more than 50 years ago [7,8]. Today, variousBY-NC-SA license.
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available and originate from bacteria (Escherichia coli), in-
vertebrates (Spodoptera frugiperda, insect cells), plants (wheat germ
embryos) and mammalians (rabbit reticulocytes). Also complete
recombinant systems designated as “Protein synthesis Using Re-
combinant Elements” (PURE) have been developed [9].
CF protein synthesis was primarily used for studying soluble
proteins, but encouraging reports about functional cell-free
expressed membrane proteins [10,11], speciﬁcally GPCRs [12,13],
continuously increased within the last 6 years. However, most of CF
expressed GPCRs were solubilized during or after CF expression
with detergents, resulting in a micellar supported structure far
from the natural lipid bilayer assisted topology. Alternatively,
reconstitution of membrane proteins into lipid membranes results
in a random distribution and reduced accessibility to ligands
[14,15]. Currently, cell-free approaches showed the expression and
co-translational insertion of GPCRs directly into a lipid bilayer
[16,17], in “nanodiscs” which are discoidal phospholipid bilayers
stabilized by amphiphilic helical membrane proteins [18] or even in
amphiphilic block-copolymer membranes [19]. In terms of the co-
translational insertion into lipid bilayers or liposomes, a unidirec-
tional orientation of the GPCR molecules in the membrane struc-
ture is observed, since the protein synthesis machinery is added to
the exposed plane of the bilayer membrane surface [20]. An uni-
directional co-translational insertion of GPCRs into mere lipid bi-
layers is advantageous for assaying applications such as high-
throughput screening approaches, for revealing the molecular
structure e.g. by NMR, or, in general, for the assembly of biosensor
devices, based on membrane proteins.
Herein, the olfactory receptor OR5 (GenBank acc. no. P70526,
314 aa, 35.5 kDa), also designated Olfactory receptor 1 (Olfr1) or
Olfactory receptor 1469 (Olr1469), is used as a model receptor to
study the cell-free expression and membrane insertion into SUVs.
OR5 was one of the ﬁrst cloned olfactory receptors, isolated from
Rattus norvegicus [21], which speciﬁcally react with the odorous
aldehydes lyral and lilial.
Previously, we showed the functional cell-free expression and
co-translational insertion of OR5, into a tethered lipid-membrane
system by Surface Plasmon Resonance Spectroscopy (SPR)/Surface
Plasmon Fluorescence Spectroscopy (SPFS) [16]and by total internal
reﬂection ﬂuorescence microscopy (TIRF) [17]. These results indi-
cated a prevalent unidirectional orientation of the N-terminus of
OR5 on the outside of the lipid bilayer.
However, SEIRAS measurements afford an advanced experi-
mental set-up, complex surface modiﬁcations and is time
consuming, therefore cell-free expression of olfactory receptors in
SUVs provides an attractive alternative route to ligand-receptor
binding detection. SUVs, for instance, could be immobilized after
functionalization with GPCRs by cell-free expression on various
surfaces and the ligand binding could bemeasured in terms ofmass
difference by Quartz Crystal Microbalance with Dissipation Moni-
toring (QCM-D) or refractive index difference by Surface Plasmon
Resonance (SPR). One could also think about the immobilization of
the ligand in a microﬂuidic device, ﬁshing for OR5 SUVs combined
with a ﬂuorescence readout. Here the ligand is immobilized on a
surface and OR5 functionalized SUVs, containing a ﬂuorescent
membrane staining, will be enriched on the surface, whereas un-
modiﬁed SUVs will be ﬂushed though. So far we established a facile
way for the efﬁcient immobilization of lipid vesicles (SUV’seGUV’s)
on bare surfaces such as hydrophilic glass surfaces as well as hy-
drophobic polymeric ﬂow channels and gold [22].
In this work, we provide substantial biochemical indications by
radioactive labeling with [35S]-methionine and proteolytic diges-
tion assays, that the insertion of the olfactory receptor OR5 into
liposomes by CF-synthesis resulted in an unidirectional orientationwith the binding side exposed into the aqueous space for ligand
screening applications. We also investigated whether the expres-
sion and membrane insertion of OR5 depends on the origin of the
cell-free expression system, which could modulate the post-
translational modiﬁcation and folding process. Therefore we
compared several cell-free expression systems, based on bacteria,
insects, wheat germ and rabbit reticulocytes, concerning OR5
expression and membrane insertion.
2. Materials and methods
2.1. Plasmids
The odorant receptor OR5 (GenBank acc. no. 70526), also
designated as Olfactory receptor 1 (Olfr1) or olfactory receptor
Olr1469, was previously cloned into the expression vector pTNT
(Promega, Mannheim, Germany, GenBank acc. no. AF479322) and
named pTNT-OR5 [16]. The cloning of the ﬂuorescent fusion protein
OR5-EYFP (chain A, Green Fluorescent Protein (65e67 replaced By
Cro, S65T Substitution, Q80R), GenBank acc. no. 1EMG_A) into the
pCMVTNT vector (Promega, GeneBank acc. no. AF477200) was
named pCMVTNT-OR5-EYFP. The pCMVTNT vector is suitable for
cell-free expression by T7 and SP6 polymerase promoters or in vivo
expression by a cytomegalovirus (CMV) enhancer/promoter. First,
OR5 was subcloned from pTNT-OR5 into the pCMVTNT vector by
PCR (primer EcoRI forward: TCGAGAATTCTTTTTTTTTTAAACCACC
ATGG, primer KpnI reverse: TTTGTGGTACCTAGGTTTAGTTGAATT
TTTC) and restriction digestion with EcoRI and KpnI. EYFP was
ampliﬁed by PCR (primer SalI forward: TTTAGTCGACATGGTGAGC
AAGGGCGAGG, primer NotI reverse: TTTTGCGGCCGCTTACTTGTA-
CAGCTCGTC) from pEYFP-N (Clontech) and fused C-terminal to OR5
by restriction digestion with SalI and NotI. The ﬁnal construct was
free of mutations as proved by sequencing. Detailed sequence in-
formation of the vectors is listed in the supplementary part (S1).
2.2. Cell-free protein expression
The odorant receptor OR5 was expressed with rabbit reticulo-
cyte lysate (RRL, TNT quick coupled transcription/translation,
Promega), bacteria lysates (B, E. coli S30 T7 High Yield Protein
Expression System, Promega), insect cell-lysates (IC, EasyXpress
Insect Kit II, Qiagen) and wheat germ extract (WG, TNT T7/SP6
coupled wheat germ extract, Promega) following the manufac-
turer’s protocols with 1 mg of cDNA in 50 mL reaction volume which
equals 8 nM of pTNT-VSV-OR5 and 5.4 nM of pTNT-VSV-OR5-EYFP
plasmid. Radioactive labeling was performed with an aqueous so-
lution of EasyTag L-[35S]-methionine (500 mCi, Perkin Elmer) with
a ﬁnal concentration of 1% v/v per reaction. CF-reactions were
supplemented with indicated concentrations of dio-
leoylphosphatidylcholine (DOPC, Avanti Polar Lipids, Alabasta, AL,
USA) or soybean phosphatidylcholine (PC, Avanti Polar Lipids) li-
posomes giving a ﬁnal concentration of 200 mM.
2.3. Lipid vesicle preparation
Phospholipids were bought from Avanti Polar Lipids (Alabaster,
AL, USA). Small unilamellar vesicles (SUV) of dioleoylphos
phatidylcholine(DOPC, 2 mM) were prepared from a 10 mM stock
solution in chloroform. Brieﬂy, 500 mL stock solution were pipetted
into a 50 mL glass vial. The solvent was evaporated under a stream
of nitrogen, and the lipid ﬁlm was dried for at least 2 h under
vacuum (1  102 bar). The lipid ﬁlm was rehydrated as multi-
lamellar vesicles in 5mL autoclaved ultra purewater by three cycles
of vortexing, freezing in liquid nitrogen, and thawing at 40 C in a
water bath. SUVs were prepared by extruding multilamellar
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size, Avestin, Ottawa, Canada) with a hand held vesicle extruder
(LipoFast, Avestin). Aliquots were stored at 20 C until use. The
soybean-phosphatidylcholine (PC) (1, 10, 50 mg/mL) vesicles were
prepared analogously.
2.4. SDS-PAGE and autoradiography
Reaction products were separated by SDS-PAGE using 10%
NUPAGE Bis-Tris gels (Life Technologies, Darmstadt, Germany) with
NUPAGE MES buffer (Life Technologies, Darmstadt, Germany) or by
NUPAGE Tricine 10e20% (Life Technologies, Darmstadt, Germany)
with Tricine buffer (Life Technologies, Darmstadt, Germany).
Protein sizes were determined by comparison with pre-stained
protein molecular weight marker See Blue Plus2 (Life Technologies,
Darmstadt, Germany) and radio-labeled [14C]- marker (GE health-
care, Frankfurt, Germany). The protein bands have different
mobility depending on the SDS-PAGE buffer system. The gels were
vacuum dried (gel dryer 583, Biorad) for 2 h at 80 C or overnight
before autoradiograms (Kodak BioMax MR ﬁlm, Perkin Elmer).
Autoradiography blots were imaged with a LAS3000 unit (Fujiﬁlm)
and quantitative image analysis performed with Fiji (open source
software).
2.5. Protease digestion assay
Protease digestion was performed immediately after CF
expression. Therefore 25 mL of the CF-reaction was transferred in a
fresh reaction tube and treated with 1 mg/mL Proteinase K (900 u/
mL, 47.6 u/mg, Fermentas) for 2 h at 37 C or indicated concen-
trations of Endoproteinase GluC (sequencing grade without impu-
rities, no activity information, Roche Diagnostics, Mannheim,
Germany) or Endoproteinase GluC (38.3 mmol/min/mg, NEB,
Frankfurt, Germany) for 2 h at 25 C. The reaction was stopped by
treatment with denaturing loading buffer for SDS-PAGE (NUPAGE
LDS loading buffer, 4X, Invitrogen) and 50 mM dithiothreitol (DTT)
(NUPAGE reducing agent, 10X, Invitrogen) for 15 min at 37 C.
3. Results and discussion
3.1. Cell-free expression and proteolytic assay for membrane
insertion
Olfactory receptors, as members of the rhodopsin-like GPCR
family, are predicted to have amostly a-helical structurewith seven
transmembrane helices, a soluble N-terminal part outside the
plasma membrane and a C-terminal part inside the cytoplasm. The
insertion of OR5 in unilamellar liposomes was analyzed by radio-
active labeling of OR5 with [35S]-methionine during cell free
expression and a subsequent digestion with the unspeciﬁc serine
protease Proteinase K. Fig. 1A sketches the principle of the pro-
teolytic assay. The transmembrane (TM) domains and the internal
loops of OR5 were protected by the lipid bilayer and only the
external loops were accessible and digested by the protease [20].
Afterward, the protease protected TM domains were separated by
gel electrophoresis and visualized by autoradiography.
In order to analyze the protease digestion pattern, we per-
formed theoretical predictions of the seven transmembrane do-
mains based on the primary protein structure with different open
source web tools as well as by molecular modeling. The predictions
of the seven transmembrane domains varied slightly depending on
the applied algorithms from EMBnet (Swiss), HMMTOP (Hungarian
Academy of Science) and Predict Protein(Columbia University). The
SOSUI (Nagoya University) and TMHMM (CBS, Denmark) algorithms
predicted six transmembrane domains and were not considered inthe following. The hydrophobic transmembrane fragments were
theoretically determined for two possible cases of protein insertion
into the liposomes membrane: external N-terminus or external C-
terminus. Based on the assumption that the N-terminus is located
outside the liposomes, four transmembrane fragments with a size
of approximately 5, 6, 7, and 8 kDa were predicted, with the lowest
[35S]-methionine labeling intensity for the 7 kDa fragment. If the C-
terminus would be located outside of the liposomes, fragments of
approximately 6 and 9 kDa and two fragments around 7 kDa, all
with similar labeling intensities, can be predicted (Fig. 1A).
No lipid membrane insertion of OR5 would result in a multitude
of small protein fragments (less than 1 kDa), which would be too
small for a detection by SDS-gel electrophoresis and autoradiog-
raphy (Fig. 1B) and no signal would be visible in this case, thus the
insertion can be proved.
Fig. 1C shows the experimental results for expression and pro-
tease digestion of radioactive labeled OR5, and the EYFP fusion
protein OR5-EYFP. Both proteins were synthesized by a coupled
rabbit reticulocyte lysate supplemented with unilamellar DOPC
vesicles (2 mM) and [35S]-methionine. The odorant receptor OR5
(36 kDa) and the fusion protein OR5-EYFP (63 kDa) showed similar
expression levels and they migrate slightly faster than expected
with an apparentmolecular weight ofw25 kDa (OR5) andw50 kDa
(OR5-EYFP) (Fig. 1C, lane 2 and 3). A similar behavior was observed
for the odorant receptor hOR17-4 [5]. This mismatch in protein size
and migration in the Western blot is called gel-shifting and is
known for helical membrane proteins. The helical hydrophobic
membrane regions and incomplete protein denaturation cause an
anomalous SDS binding to membrane proteins. Therefore mem-
brane protein migration on SDSegels, especially with higher mo-
lecular weights, does not correlate with their actual molecular
weight [23].
The Proteinase K digestion of OR5 resulted in one strong frag-
ment (w8 kDa) and one weak fragment (w5 kDa) (Fig. 1C, lane 5).
This digestion fragments proofed the membrane insertion of OR5,
however, no conclusion about the orientation could be drawn from
the Proteinase K digestion pattern because the predicted fragments
for both orientations, N- or C-terminus outside, are in a similar
range. Interestingly, OR5-EYFP showed exactly the same Proteinase
K digestion pattern as OR5, indicating that the OR5 part of the EYFP-
fusion protein is folded and inserted in a similar manner (Fig. 1C,
lane 6), whereas the soluble EYFP seems to be located outside of the
liposomes and digested. These results veriﬁed the membrane
insertion of in vitro expressed OR5 by radioactive labeling and
Proteinase K digestion since distinct protein digestion bands be-
tween 5 and 8 kDa were detectable.
To unravel the orientation of the OR5 membrane insertion we
did an amino acid structure based search for proteases, providing
an asymmetric digestion pattern depending on N- or C-terminal
outside orientation. Therefore we created artiﬁcial peptides
composed of the external loops either for the N- or C-terminal
orientation and performed a digestion analysis with Peptide Cutter
(www.expasy.ch). From 37 tested proteases, only Endoproteinase
GluC (Glutamyl endopeptidase/Staphylococcal peptidase I) showed
a clear asymmetric digestion pattern which allowed discrimination
by SDS-PAGE analysis based on different sized OR5 fragments.
Endoproteinase GluC is a selective Serine endopeptidasewhich cuts
C-terminal to glutamic acid (E) and C-terminal to aspartic acid (D),
but 300 times less efﬁcient compared to glutamic acid. Assuming
that the C-terminus would be outside of a liposome. The Endo-
proteinase GluC digestion of OR5would result in two fragments (35
and 1.5 kDa) as shown in Fig. 2A. For the N-terminal outside
orientation the complete digestion of OR5 would generate 7 frag-
ments (0.8, 0.9, 2, 3, 5, 8, 17 kDa). At least two of those fragments
contain a higher number of [35S]-methionine label and are
Fig. 2. Theoretical prediction of OR5 protein fragments. The fragments were produced by proteolytic digestion with the asymmetric cutting protease Endoproteinase GluC (A, B)
and corresponding experimental results (C). (A) Lipid membrane insertion of OR5 with C-terminal outside orientation of OR5 would result in one detectable protein fragment of
35 kDa. Lower amount of [35S]-methionine units indicated by graycolor, (B) Lipid membrane insertion of OR5 with N-terminal outside orientation would result in 7 protein
fragments, thereof two fragments with high [35S]-methionine labeling (17 and 5 kDa). (C) Representative autoradiography of SDS-PAGE (10e20% Tricine gel) separated proteins
Representative autoradiography of SDS-PAGE separated OR5 produced by coupled RRL (Promega) supplemented with 2 mM DOPC liposomes and [35S]-methionine. Endoproteinase
GluC digestion (NEB/Roche, 25 C, 2 h) was performed in a concentration range of 0.1e5 mg/mL.
Fig. 1. Comparison of OR5 protein fragments produced by proteolytic digestion with Proteinase K and corresponding in silico analysis. A) Lipid membrane insertion of OR5
with N-terminal outside orientation would result in deﬁned protein fragments of 5, 6, 7, 8 kDa or 6, 7, 7, 9 kDa with C-terminus outside orientation. Lower intensity of [35S]-
methionine is indicated by graycolor. B) Expression of OR5 without membrane insertion would result in a multitude of non-detectable small protein fragments. C) Representative
autoradiography of SDS-PAGE (10% BiseTris gel) separated OR5 and OR5-EYFP produced by coupled RRL (Promega) supplemented with 2 mM DOPC liposomes and [35S]-methi-
onine. Proteinase K (1 mg/mL, 37 C, 2 h) digested samples were indicated with ‘þ Proteinase K’. Samples from left to right: control without cDNA (lane 1), OR5 (lane 2), OR5-EYPF
(lane 3), control without cDNA plus Proteinase K (lane 4), OR5 plus Proteinase K (lane 5), OR5-EYFP plus Proteinase K (lane 6).
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and 17 kDa) (Fig. 2B). A detailed description of the digestion frag-
ment analysis is given in the supplement (Table. S1 and S2).
The SDS-PAGE/autoradiography analysis of [35S]-methionine
labeled OR5 (RRL, Promega) resulted in a protein band of 25e
33 kDa for undigested OR5 (36 kDa) as shown in Fig. 2C (lane 1 and
6, we used two different size markers which differs slightly in the
higher molecular weight range). The Endoproteinase GluC diges-
tion of OR5 resulted for the lowest protease concentration (0.1 mg/
mL) in two fragments with sizes of approximatelyw5 andw25 kDa
respectively (Fig. 2C, lane 5 and lane 10). For higher protease con-
centration (1e5 mg/mL) three fragments with sizes ofw5,w21 and
w25 kDa, respectively, were obtained (Fig. 2C, lane 7e9). The 5 kDa
fragment is in consensus with the digestion fragment prediction
(Fig. 2B) for the N-terminus outside orientation. The 21 kDa and
25 kDa bands probably correspond to partial digestion fragments of
OR5. An exact comparison between experimental and predicted
fragments with SDS-PAGE is difﬁcult for higher molecular weights
because of the lower resolution. However, in the case of a C-ter-
minus outside orientation, there would be no detectable shift be-
tween the undigested OR5 band (36 kDa) and the digested OR5
band (35 kDa), as seen in Fig. 2C (lane 2-5 and lane 7e9). Therefore
we conclude from the Endoproteinase GluC digestion fragment
analysis a uniform N-terminal outside orientation of OR5, which
strengths former optical studies by SPR/SPFS and TIRF microscopy
[16,17].
3.2. Comparison of different cell free expression systems
To identify a commercial CF protein expression system in terms
of high protein yield and membrane insertion for OR5, we
compared several commercial cell-free expression systems based
on bacteria (B, E. coli S30 T7 High Yield Protein Expression System,
Promega), insect cells (IC, EasyXpress Insect Kit II, Qiagen), wheat
germ (WG, TNT T7/SP6 coupled wheat germ extract, Promega) and
rabbit reticulocytes (RRL, TNT quick coupled transcription/trans-
lation, Promega).Fig. 3. Comparison of different cell free expression systems. (A) Expression of 35S-methio
lysate. (B) Corresponding Protease K digestion assay to A. (C) Expression of [35S]-methion
Corresponding Protease K digestion assay to C.Fig. 3A shows the protein expression bands of OR5 and OR5-
EYFP with sizes of w30 kDa and 50 kDa, respectively, produced
by IC and RRL. The membrane insertion was proven by radioactive
labeling of OR5 with [35S]-methionine and subsequent Proteinase K
digestion. When OR5 was synthesized by RRL, we observed two
characteristic membrane preserved Proteinase K digestion bands of
OR5 and OR5-EYFP with sizes of 5 kDa and 8 kDa, respectively
(Fig. 3B, lane 4, 5 compare Fig. 1C). Interestingly, Proteinase K
digestion of OR5 expressed by IC did not result in any detectable
digestion band (Fig. 3, lane 1, 2).
OR5 protein expression by RRL andWG resulted in similar sized
expression bands ofw30 kDa (Fig. 3C, lane 2 and 4), whereas OR5
expression by B resulted in two protein bands. One same in size to
the w30 kDa RRL and WG expression band and one intense band
with lower molecular weight w21 kDa (Fig. 3C, lane 6). We esti-
mated the expressed protein concentration from the autoradio-
gram based on the assumption that the C14 labeled protein marker
equals a concentration of 10 mg protein per lane. According to this,
the concentration of synthesized OR5 was in the range of 0.2e
1.8 mg/mL (RRL w0.2 mg/mL, IC w0.7 mg/mL, WG w0.8 mg/mL,
and B w1.8 mg/mL).
Again, the OR5membrane insertionwas veriﬁed by Proteinase K
digestion for the RRL, WG and B expression systems (Fig. 3D), but
the band sizes and intensities representing the amount of inserted
OR5, varied for the different expression systems. The digestion
patterns of OR5 expressed by RRL and B systems were quite similar
in size (w5, 8 kDa), but with a higher fraction of membrane
insertion if OR5 was expressed by RRL, although the undigested
expression bands showed a generally higher protein yield for the B
system (Fig. 3 C). Interestingly, Proteinase K digestion fragments of
OR5 expressed by the WG extract were smaller (w5, w6 kDa),
suggesting a diverse co- or posttranslational insertion.
In summary, OR5 could be expressed with all four commercial
expression systems (IC, RRL,WG and B). OR5 expressed by the RRL
and B showed similar membrane insertion bands, with a higher
fraction of membrane insertion for the RRL. In contrast, no lipid
membrane insertion of OR5 was observed for the insect basednine labeled OR5 (lane 1, 3) and OR5-EYFP (lane 2, 4) by insect cell extract IC and RRL
ine labeled OR5 by RRL, WG and B. Without cDNA control (), with cDNA (þ). (D)
Fig. 4. Optimization of OR5 expression yield (A) and membrane insertion (B). A)
Representative autoradiography of SDSePAGE separated OR5 produced by coupled RRL
(Promega) supplemented with DOPC or soybean liposomes at different concentrations
and [35S]-methionine. B) Expression and Proteinase K digestion of OR5 by coupled RRL
without (lane 1, 2) and with the supplement of soybean PC (lane 3, 4). (þ) With
Proteinase K.
S. Ritz et al. / Biochimie 95 (2013) 1909e19161914expression system and a different insertion pattern was observed
for the WG expression system.
The differences in protein expression and membrane insertion
patterns were presumably caused by species related factors for
posttranslational modiﬁcations, like e.g. N-linked glycosylation of
OR5 on the conserved NXS/T sequence at the N-terminus, and
different insertion mechanisms (like co- or posttranslational
insertion), which we did not further address in this study. Today,Table 1
Cell-free expression and co-translational insertion of membrane proteins in lipid based
Membrane protein Origin Extract Matri
a-Hemolysin-GFP Procaryotic E. coli (s.m.) SUVse
Apo cytochrome b5-GFP Eucaryotic WG (c.) GUVs
Aquaporin Z E. coli E. coli LUVs
ATP synthase Procaryotic E. coli (s.m.) Lipsom
b2-adreneric receptor-T4
lysozyme (b2AR-T4L)
Human-procaryotic E. coli (c.) Nanod
Bacteriorhodopsin Procaryotic E. coli SUVs
Bacteriorhodopsin,
Apolipoprotein A (ApoA)
Procaryotic E. coli (c.) Nanod
Connexin 43 Rat E. coli (PURE) SUVs
Connexin Cx43, Cx32 Rat RRL (c.) Liposo
Cytochrome bo3 ubiquinol oxidase Procaryotic E. coli (c.) Tethe
Dopamin receptor DRD2 Human RRL (c.) Polym
Mannitol permease MtlA E. coli E. coli (s.m.) E. coli
Mechanosensitive channel MscL Procaryotic E. coli (c.) Liposo
Multidrug transporter EmrE E. coli E. coli Nanod
OEP24 Pea E. coli (c.) Liposo
Olfactory receptor OR5 Rat RRL (c.) Tethe
OmpA E. coli E. coli (PURE) E. coli
Potassium channel KcsA Procaryotic E. coli LUVs
Serotonin receptor Human RRL (c.) Nanod
Stearoyl-CoA desaturase hSCD1,
Cytochrome b5 Cytb5
Human, mouse,
Mycobacterium
tuberculosis
WG (c.) SUVs
Tetracycline pump TetA Procaryotic E. coli (s.m.) E. coli
s.m. self-made; c. commercial; DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPE
phosphoglycerol; POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; PG phosp
Dipalmitoyl-sn-glycero-3-phosphorylcholine; TE total E. coli lipid extract.most membrane proteins and specially GPCRs are expressed by
bacteria related cell-free expression systems [18,24] optimized for
high protein yields. However, based on the highest yield of OR5
membrane insertion and concerning the genetic origin of
mammalian OR5, the RRL system was selected for further studies.
3.3. Optimization of OR5 membrane insertion
In the following, we focused on the optimization of the efﬁ-
ciency of expression and membrane insertion of OR5 produced by
RRL. First, we varied the liposome concentration (0.1e5 mg/mL)
and composition (pure DOPC or soybean PC). The addition of DOPC
liposomes showed no signiﬁcant effect on the overall expression
yield of OR5 in comparison to the control without the addition of
liposomes (Fig. 4A, lane 2e4), whereas supplementation of the RRL
with soybean PC liposomes showed a concentration dependent
inhibitory effect (>1mg/mL) on the expression of OR5 (Fig. 4A, lane
5e7). We cannot rule out, if this inhibitory effect could also be due
to the source of the soybean PC. Although there was no enhancing
effect on the overall protein yield at a soybean PC concentration of
0.1 mg/mL, the Protease K digestion assay showed a 70 fold
stronger digestion band intensity for the soybean PC liposome
supplemented reaction (Fig. 4B, lane 4) compared to the reaction
without liposomes (Fig. 4B, lane 2).
4. Conclusion
We present the successful and robust in vitro synthesis of
mammalian odorant receptor species OR5 inside an artiﬁcial
context and collected strong evidence for an uniform N-terminus
outside orientation of the odorant receptor OR5, conﬁrmed by a
protease digestion assay. Furthermore, OR5 membrane topology is
depended on the genetic origin of the expression system: rabbit
reticulocyte lysates and bacterial lysates lead to comparable
membrane insertion patterns, but with higher fractions of mem-
brane insertion for the mammalian system. Expression of OR5 bysystems.
ces Quality control Ref.
GUVs (POPC), supported membrane Activity [28]
(egg yolk phosphatidylcholine, DOPC, DMPC, CH) Activity [29]
(DOPC) Activity [30]
es (DOPC, DOPE, DOPG) Activity [31]
iscs Activity [18]
(DOPC, DMPC, DPPC) Activity [20]
iscs (ApoA, DMPC) Expression [32]
(DOPC, DPPC, DOPG) Activity [33]
mes (Egg yolk PC) Activity [34]
red lipid membrane (DMPE/PC, DMPE/TE) Activity [35,36]
ersomes Activity [19]
inner membrane vesicles Partial insertion [37]
mes (Asolectin IV-S) Activity [38]
iscs (ApoA1, cholate, DMPC) Activity [39]
mes (DOPC, DOPE, DMPA, Cholester) Activity [40]
red lipid membrane (DMPE, PC) Activity [16,17]
inner membrane vesicles (urea washed) Reconstitution [41]
(DOPC, DOPE, PG, TE) Tetramerization [42]
iscs (ApoA1, cholate, DMPC) Expression [43]
(soybean tissue extract) Activity [44]
inner membrane vesicles Activity [37]
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPG 1,2-dioleoyl-sn-glycero-3-
hatidylglycerol; DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC 1,2-
S. Ritz et al. / Biochimie 95 (2013) 1909e1916 1915wheat germ extract resulted in a divergent membrane insertion
pattern. Expression in an insect cell extract showed no detectable
membrane insertion at all.
In vivo, co-translational insertion of membrane proteins into the
endoplasmatic reticulum is either supported by catalyzing enzyme
machineries like signal recognition particles (SRPs) and the Sec
translocation pathway [25] or posttranslational e as recently
identiﬁed - by cytosolic chaperones like TRC40 (transmembrane
domain recognition complex of 40 kDa) [26,27]. In contrast, cell-
free expression of manifold functional membrane proteins inser-
ted either into liposomes, supported lipid bilayers or nanodiscs has
been reported, but the detailed mechanisms remain unclear
(Table 1).
Here, we showed that the choice of the cell-free expression
system signiﬁcantly inﬂuences membrane insertion of a polytopic
olfactory receptor. The use of commercial cell-free expression sys-
tems provides on the one hand an easy access to different systems
and high reproducibility, but coincidental a lack of knowledge
about the detailed composition of the system.
We suppose that some fundamental aspects, such as catalyzing
parts, concentration levels, and intrinsic membrane components,
present in the respective cell lysates, inﬂuence the resulting GPCR-
membrane assembly. We also assume that spontaneous insertion
into liposomes as spherical alternative structures to planar lipid
membranes is mainly supported by lipid-protein interactions facing
an important role for hydrophobic and ionic driven mechanisms.
There is a still on-going debate about the main driving force for
transmembrane insertion: catalyzing enzymes and/or charged
driven lipid-protein and hydrophobic interactions. A systematic
variation of lipid composition (lipid head group polarity, alkyl chain
length, saturated, unsaturated, mixtures) or amphiphilic polymer-
somes on the inﬂuence of membrane protein insertion would be
very interesting future work.
However, the major ﬁnding of this work is the feasibility of
unidirectional and functional cell-free expression of olfactory re-
ceptors, as examples for a subtle membrane protein species from
the GPCR family. This is an important prerequisite for further
improving the membrane insertion process of in vitro synthesized
membrane proteins toward in vitro generated, deﬁned and robust
protein functionalized interfaces for biosensing applications.
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